2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
3
Status
Unknown
2
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
418
INDUSTRY
257
NETWORK
11
NIH
10
UNKNOWN
6
OTHER_GOV
4
Study Type
Interventional
3
Observational
1
Sponsor
Cancer Type
Gastrointestinal
2
Breast
2
Conditions
Breast Neoplasms
2
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Neoplastic Cells, Circulating
1
Gastric Adenocarcinoma
1
Interventions
Cisplatin
50
Capecitabine
42
apatinib
34
Radiotherapy
33
Oxaliplatin
33
Gemcitabine
33
Cyclophosphamide
32
Drug Therapy
31
Paclitaxel
30
Carboplatin
29
tislelizumab
27
Irinotecan
27
Fluorouracil
26
Docetaxel
26
Bevacizumab
23
Surgical Procedures, Operative
21
Nivolumab
19
pembrolizumab
18
fludarabine
18
Metformin
16
Exercise
16
camrelizumab
15
Radiation
15
S 1 (combination)
14
Control Groups
14
Blood Specimen Collection
14
Pemetrexed
13
Standard of Care
12
anlotinib
11
Neoadjuvant Therapy
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
OTHER_GOV
×
130-nm albumin-bound paclitaxel
×
Clear all
NCT07610629
2026-05-28
RA-A-NP
Henan Cancer Hospital
Phase 2
Not yet recruiting
50 enrolled
NCT05953909
2023-07-20
ERI-Based-01
Fujian Cancer Hospital
Unknown
120 enrolled
NCT02707159
2023-03-08
PACT-ACT-v6
Helse Stavanger HF
Phase 2
Completed
70 enrolled
NCT01830244
2017-07-02
Neonab
Barwon Health
Phase 2
Unknown
60 enrolled